The latest from BioStock
» Abliva leads the fight against mitochondrial diseases
» BioInvent's CMO comments on the presentation at ESMO
» Investing in life science: From Seed to Success 2024
» Future obesity treatment: Iconovo invests in intranasal semaglutide
» BioInvent makes a strong entrance at ESMO in Barcelona
Read the newsletter for v.37 here.
See all presentations and panels from BioStock Investing in Life Science – below.
The latest news
AcuCort announces that Zeqmelit has been launched in Norway and Finland. Read more.
Implantica announces data from an independent study of 158 RefluxStop-patients from two centers in Germany. Read more.
Mentice and German Society of Interventional Cardiology announces strategic partnership. Read more.
CS MEDICA announces approval of CANNAS in Malaysia and trademark registration in Thailand. Read moreThe company also announces strategic partnership with Scan MedPartners for the American market. Read more.
Saniona receives regulatory approval for biomarker study with SAN711. Read more.
Guard Therapeutics Phase II results published in leading scientific journal. Read more.
Nanexa begins the last dose group in the phase I study with NEX-22 for the treatment of type II diabetes. Read more.
IRLAB is granted additional patents for its drug candidate pirepemate and thereby extends patent protection in the United States. Read more.
Although By having granted a patent, regarding Orthosis control from the US Patent Office. Read more.
Elektas AI-powered adaptive CT-Linac, Elekta Evo, receives CE marking. Read more.
AstraZeneca Phasenra approved in the US for eosinophilic granulomatosis with polyangiitis. Read more.
PMD Device Solutions RespiraSense-technology shows ability to predict 7-day mortality. Read more.
ArcticZymes announces new whitepaper published in Select Science. Read more.
Photocures Partner Asia presents efficacy data for non-surgical treatment of cervical HSIL. Read more.
Neola Medical showcases GASMAS technology at Xth Recent Advances In Neonatal Medicine Congress. Read more.
S2Medical announces preliminary outcome of the company's rights issue. Read more.
BICO presents updated strategy at Capital Markets Day today. Read more.
Invent Medic publishes information memorandum regarding the upcoming rights issue. Read more.
Hamlet BioPharma invites you to a digital investor meeting on September 18th. Read more.
Inger Rydin appointed as Integrums interim COO and takes office immediately. Read more.
Ziccum announces the outcome of the exercise of warrants of series TO5. Read more.
Perpetua Medical completes the assignment as planned at Mangold Fund Commission as a liquidity guarantor. Read more.
Reports
Communiqués
Summons
This morning's price development
Index: OMXS30 -0,54% Healthcare -1,07%
| Winner | Förlorare |
| Tendo +24,7% | Immunovia -14,1% |
| Scandion Oncology +17,1% | Bio-Works Technologies -11,6% |
| Spago Nanomedical +13,3% | Enzymatica -10,4% |
| Cyxone +10,0% | Tolerance -9,7% |
| ScandiDos +9,5% | PharmaLundensis -8,0% |